CSF2 and Pneumocystis infectious disease: Based on these findings, we further elaborate the detailed effects of glucocorticoids on various macrophages subtypes, and suggest the potential therapeutic use of GM-CSF in improving the resistance of DEX-treated hosts against Pneumocystis infections.